Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - OPERATING EXPENSES
Operating Expenses VRDN - Viridian Therapeutics, Inc.
255 M
LAST VALUE
75.53%
2 YEAR CAGR
43.77%
5 YEAR CAGR
60.37%
10 YEAR CAGR